Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Trading Statement

6 Jan 2010 07:00

RNS Number : 0818F
Tarsus Group PLC
06 January 2010
 



6 January 2010

Tarsus Group plc

Trading Update

Tarsus Group plc ('Tarsus' or 'the Group'), the international business-to-business media group, expects full year 2009 adjusted pre-tax profits to be in line with the Board's expectations.

Our strategy has been to continue to increase the Group's focus on its emerging markets division. These operations contributed approximately 33% of Group revenues in 2009, with management today announcing that it expects this proportion to increase to around 50% by 2013.

Group like-for-like revenue growth for the year ended 31 December 2009 has seen an increase of approximately 11% (1% excluding any benefit from currency movements). Like-for-like exhibition volumes (net square metres sold) were slightly up and encouragingly, total attendances were up 7% - ahead of our expectations.

Recent Trading

Trading since our last Interim Management Statement (IMS) issued on 19 November is set out below.

In summary, the emerging markets continued to perform well, while trading in Europe has remained challenging. We are also pleased to see early signs of recovery in the US market.

Emerging Markets

The second edition of the Dubai Airshow under our ownership took place in November and delivered revenues 19% ahead of the equivalent event in 2007. Attendance at this business-to-business exhibition, the Group's largest, was up an exceptional 18%. Re-bookings for the 2011 event are substantially ahead of the previous cycle.

Our strategy of increased focus on emerging markets was validated by the outstanding performance of Labelexpo Asia, with revenues up 46% and attendance up 19%. In volume terms, Labelexpo Asia is now our sixth largest exhibition.

We are continuing to build and deepen our Chinese business and have now set up a subsidiary company - wholly owned foreign enterprise (WOFE) - in Shanghai.

Europe 

The French business has performed broadly in line with our reduced expectations at the interim stage with full year revenues declining 12% compared with 2008Visitor attendance was up approximately 3%.

US

Against a difficult economic background our Medical division saw total revenues fall 7% in 2009 primarily reflecting a change in the mix towards higher margin education and training streams. Encouragingly, revenues for the Las Vegas event in December were unchanged on 2008

 

Outlook for 2010

Within each two-year cycle, odd years are by far the larger in profit terms for the Group as they contain the Dubai Airshow, as well as both Labelexpo Europe and Labelexpo Asia, replaced in even years by Labelexpo Americas

The Group's large events have continued to perform extremely well with smaller products, in line with the rest of the industry, being impacted by difficult market conditions.

There are two significant events in the first quarter of 2010 - the Off-Price Show in Las Vegas where current indications are that the exhibition will produce revenues comfortably ahead of the equivalent event in 2009; and the Mod'amont fashion accessories exhibition in Paris which is tracking a little behind where it was at a similar stage last year.

Bookings for the small Dubai exhibitions scheduled for the first quarter of 2010 are tracking slightly ahead of their previous editions.

During the last few years the Group's management has been focused on developing a portfolio of events that is diverse by both industry and geography in order to ensure that Tarsus is resilient throughout the economic cycle. This strategy, combined with a focus on market-leading events with an increasing bias towards emerging markets, leaves the Group well positioned as economic growth picks up. 

 

Tarsus Group plc:

Douglas Emslie, Group Managing Director 020 8846 2700

Ashley Milton, Group Finance Director 020 8846 2700

Media:

Madano Partnership 

Matthew Moth 020 7593 4000

Investors/Analysts:

IRfocus

Neville Harris 020 7593 4015

Scott Harris

Stephen Scott, Jeremy Wiseman 020 7653 0030

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUVABRRVAARAR
Date   Source Headline
16th May 20197:00 amRNSTrading Update
9th May 20196:19 pmRNSBlock Listing Six Monthly Return
30th Apr 201910:14 amRNSTotal Voting Rights
16th Apr 20192:40 pmRNSDirector/PDMR Shareholding
2nd Apr 20193:43 pmRNSBlock listing Interim Review
1st Apr 201910:44 amRNSTotal Voting Rights
19th Mar 201911:42 amRNS2018 Annual Report
8th Mar 20194:36 pmRNSPrice Monitoring Extension
27th Feb 20197:00 amRNSFinal Results
6th Feb 20194:35 pmRNSPrice Monitoring Extension
31st Jan 201911:53 amRNSTotal Voting Rights
30th Jan 20197:00 amRNSOption agreement re Tarsus Connect
16th Jan 20194:22 pmRNSApplication for Admission
14th Jan 20197:00 amRNSYear-end Trading Update
13th Dec 20184:48 pmRNSScrip Dividend Circular (the "Circular")
30th Nov 20183:10 pmRNSTotal Voting Rights
20th Nov 20181:44 pmRNSApplication for Admission
6th Nov 20187:00 amRNSCapital Markets Seminar and Trading Update
1st Nov 20182:56 pmRNSTotal Voting Rights
18th Sep 20186:20 pmRNSDirector/PDMR Shareholding
14th Sep 201812:06 pmRNSResults of Placing
14th Sep 20187:00 amRNSAcquisitions and Placing of New Ordinary Shares
10th Sep 20183:18 pmRNSBlock Listing Six Monthly Return
31st Aug 20183:39 pmRNSTotal Voting Rights
24th Aug 201811:17 amRNSHalf-year Report
1st Aug 201811:54 amRNSTotal Voting Rights
26th Jul 20187:00 amRNSHalf-year Report
13th Jul 20182:34 pmRNSApplication for Admission - scrip dividend shares
13th Jul 20182:18 pmRNSDirector Declaration
21st Jun 20181:52 pmRNSResult of AGM
18th Jun 20183:37 pmRNSHolding(s) in Company
12th Jun 20184:41 pmRNSDirector/PDMR Shareholding
8th Jun 20183:45 pmRNSScrip Dividend Circular
1st Jun 201812:31 pmRNSTotal Voting Rights
21st May 20186:10 pmRNSNotice of AGM
17th May 20187:00 amRNSTrading Update
9th May 20187:00 amRNSBoard Changes
9th May 20187:00 amRNSBlock Listing Six Monthly Return
1st May 201811:45 amRNSTotal Voting Rights and Capital
20th Apr 201812:15 pmRNSDirector/PDMR Shareholding
20th Apr 201812:14 pmRNSDirector/PDMR Shareholding
18th Apr 20184:29 pmRNSNotification of Transactions
29th Mar 201810:50 amRNSTotal Voting Rights
22nd Mar 20185:01 pmRNS2017 Annual Report
9th Mar 20183:54 pmRNSDirector/PDMR Shareholding
6th Mar 201810:18 amRNSBlock Listing Six Monthly Return
5th Mar 20185:06 pmRNSDirector/PDMR Shareholding
28th Feb 20187:00 amRNSFinal Results
31st Jan 20189:40 amRNSTotal Voting Rights
12th Jan 201810:30 amRNSApplication for Admission - scrip dividend shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.